$ALT (+1,42 %) is now performing again after the last trial report and crash.

Of course, there is a lot of risk at this early stage.

Let's see how the FDA sees it later on.

Current developments against:

* Obesity and its associated diseases

* MASH (Metabolic Dysfunction-Associated Steatohepatitis)

* Alcohol use disorder (AUD)

* Alcohol-Associated Liver Disease (ALD)

Earnings next week (11.11 - 15.11)

$SHOP (+0,05 %)

$SOUN

$MARA (-2,44 %)

$BABA (+2,37 %)

$CAVA

$SPOT (-4,07 %)

$AMAT (-1,38 %)

$DIS (-0,81 %)

$PLUG (+8,57 %)

$HD (+0,11 %)

$MNDY (+0,32 %)

$OXY (-0,1 %)

$RKLB (-0,23 %)

$BSEM

$ZETA (-3,24 %)

$SE (+0,35 %)

$RKT

$CSCO (-0,48 %)

$ASTS (+0,4 %)

$WULF (-4,97 %)

$ONON (+1,41 %)

$OKLO

$HUT (-3,34 %)

$NVAX (-0,55 %)

$HTZ (-4,69 %)

$LUNR

$CART

$TALN

$BITF (-3,23 %)

$GRAB (+1,32 %)

$JD (+3,55 %)

$LAZR

$ALT (+1,42 %)

$CRON (-2,29 %)

$ICL

$NICE

$CYBR (+0,39 %)

$BXSL (-0,68 %)

$DESP

$ARMK (-0,13 %)

$TSN (-1,05 %)

$RUM

$PGY

$TGI

$AAP (-0,17 %)

$AXSM (-0,71 %)

$AZN (-1,25 %)

$BILI (+2,36 %)

$LINC (+0,6 %)

$LQDA (+1,36 %)

Hi, could I have your opinions on $ALT (+1,42 %) share?

$ALT (+1,42 %) I hope things are looking up😂

$ALT (+1,42 %) What do you think of the share?

The share is very exciting and after the drop I am now hoping for a nice return of 20%-30%